» Articles » PMID: 39896805

Liver Sinusoidal Endothelial Cells Regulate the Balance Between Hepatic Immunosuppression and Immunosurveillance

Abstract

As a metabolic center, the liver prevents inappropriate immune responses to abundant dietary antigens within the liver that could result in liver injury. This self-preservation mechanism can however decrease the efficiency of immunosurveillance of malignant cells by CD8 T cells. Hepatocellular carcinoma (HCC) is initiated by chronic viral infections, chronic alcohol consumption, and/or a fatty diet that leads to liver injury, fibrosis, and cirrhosis. HCC patients have high levels of dysfunctional and exhausted T cells, however, it is unclear which stage of HCC development contributes to T cell dysfunction. Repair of liver injury is initiated by interactions between injured hepatocytes and liver sinusoidal endothelial cells (LSEC), however, chronic injury can lead to fibrosis. Here, using a diethylnitrosamine/carbon tetrachloride (DEN/CCl) mouse model of early HCC development, we demonstrate that chronic liver injury and fibrosis are sufficient to induce a CD8 T cell exhaustion signature with a corresponding increase in expression of immunosuppressive molecules on LSEC. We show that LSEC alter T cell function at various stages of T cell differentiation/activation. LSEC compete with dendritic cells presenting the same antigen to naïve CD8 T cells resulting in a unique T cell phenotype. Furthermore, LSEC abrogate killing of target cells, in an antigen-dependent manner, by previously activated effector CD8 T cells, and LSEC change the effector cell cytokine profile. Moreover, LSEC induce functional T cell exhaustion under low dose chronic stimulation conditions. Thus, LSEC critically regulate the balance between preventing/limiting liver injury and permitting sufficient tumor immunosurveillance with normal hepatic functions likely contributing to HCC development under conditions of chronic liver insult.

References
1.
Romualdo G, Prata G, Da Silva T, Fernandes A, Moreno F, Cogliati B . Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models. PLoS One. 2018; 13(9):e0203879. PMC: 6136798. DOI: 10.1371/journal.pone.0203879. View

2.
Kremer K, Buser A, Thumkeo D, Narumiya S, Jacobelli J, Pelanda R . LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation. Proc Natl Acad Sci U S A. 2022; 119(15):e2118816119. PMC: 9169816. DOI: 10.1073/pnas.2118816119. View

3.
Lau A, Thomson A . Dendritic cells and immune regulation in the liver. Gut. 2003; 52(2):307-14. PMC: 1774973. DOI: 10.1136/gut.52.2.307. View

4.
Brown Z, Heinrich B, Greten T . Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research. Nat Rev Gastroenterol Hepatol. 2018; 15(9):536-554. DOI: 10.1038/s41575-018-0033-6. View

5.
Thompson A, Conroy K, Henderson N . Hepatic stellate cells: central modulators of hepatic carcinogenesis. BMC Gastroenterol. 2015; 15:63. PMC: 4445994. DOI: 10.1186/s12876-015-0291-5. View